A mother’s heart health while she is pregnant may have a significant impact on her child’s cardiovascular health in early adolescence, according to a new study from Northwestern and Lurie Children’s Hospital.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.
Using proxy measures of preparedness for hypertension or diabetes care did not accurately assess the ability of low- and middle-income countries to treat patients, according to a study published in PLOS Medicine.
A signaling molecule produced by the lymphatic vasculature could be used to promote cardiac repair after heart attack, according to a Northwestern Medicine study published in Nature.
A gene mutation discovered in a small Amish community in Indiana has inspired the use of a new experimental drug for COVID-19 that reduces blood clotting.
In late March, the world came to a virtual standstill. The COVID-19 pandemic forced leaders around the world to limit large gatherings and shutter schools and businesses. For Feinberg’s research enterprise, this was a serious disruption — but science kept moving forward.
The presence of inflammatory proteins was associated with comorbidity burden and deteriorating heart function in patients with heart failure with preserved ejection fraction, according to a Northwestern Medicine study.
Feinberg investigators are breaking down the mechanisms of aging and designing solutions to extend healthy living.